Curing blindness by repairing corneas with invisible films

August 15, 2016, Fresh Science
Credit: Fresh Science

A patented treatment could restore eyesight for millions of sufferers of corneal disease.

The University of Melbourne–led team of researchers have grown on a layer of film that can be implanted in the eye to help the cornea heal itself. They have successfully restored vision in animal trials and are aiming to move to human trials next year.

Victor Fortmann's vision in one eye failed following a condition called bullous keratopathy. Two donated cornea transplants restored his sight for a period, but he now needs a third to restore his vision in that eye.

Over 2000 corneal transplants are conducted in Australia each year. But globally there's a shortage of donated corneas, and the resulting loss in vision affects about 10 million people worldwide.

"We believe that our new treatment performs better than a donated cornea, and we hope to eventually use the patient's own cells, reducing the risk of rejection," says Berkay Ozcelik who developed the film working at the University of Melbourne.

"Further trials are required but we hope to see the treatment trialled in patients next year," he says.

The cornea is the transparent layer at the front of the eye. To remain healthy and transparent, the cornea must remain thin. A layer of specialised cells () on its inner surface maintain the cornea's moistness by 'pumping' water out of it.

However, trauma, disease and aging can reduce the numbers of these cells, eventually causing the cornea to become swollen and cloudy, leading to vision deterioration and blindness.

The cells cannot regenerate or repair themselves. The only treatment available requires donor corneas to be transplanted into the patient's eyes. But there's a worldwide shortage of donor corneas. The transplant process damages some corneal endothelial cells, and the may still be rejected by the patient's immune system.

Berkay and his colleagues grew corneal cells on a specially developed synthetic film that could then be implanted into a patient's eye.

"The hydrogel film we have developed allows us to grow a layer of corneal cells in the laboratory," says Berkay. "Then, we can implant that film on the of a patient's cornea, within the eye, via a very small incision." Once in place the new cells restore the cornea's vital water-pumping activity, so that the cornea once more becomes transparent.

Thinner than a human hair (50µm), the hydrogel film is perfectly transparent when implanted, and allows the flow of water between the cornea and the interior of the eye. The film completely biodegrades within two months and causes no adverse immune reactions.

Berkay developed the synthetic film used to culture new corneal cells at the Polymer Science Group (the University of Melbourne), working with the Centre for Eye Research Australia. Berkay is now working in a similar field at CSIRO and is still active with the corneal film project as an Honorary Post-doctoral Fellow at the University.

Explore further: Corneal transplants, men and women don't see eye to eye

Related Stories

Corneal transplants, men and women don't see eye to eye

July 14, 2016
A new study of patients undergoing corneal transplants indicates that subtle differences between men and women may lead to poorer outcomes for a woman who has received a cornea from a male donor.

Substances found in cornea activate healing of blinding scar tissue

December 18, 2015
Doctoral student Marta Słoniecka at the Department of Integrative Medical Biology has found that the neuropeptide substance P and the neurotransmitter acetylcholine activate and enhance healing of the cornea. The two substances ...

Vision restored in rabbits following stem cell transplantation

March 9, 2016
Scientists have demonstrated a method for generating several key types of eye tissue from human stem cells in a way that mirrors whole eye development.

Simple procedure could improve treatment for common eye disease

July 13, 2016
A new, minimally invasive procedure appears to be effective for many patients with Fuchs endothelial dystrophy (FED), a common eye disease, without the potential side effects and cost of the current standard of care, a cornea ...

First corneal stem cell transplant conducted in Ireland

June 10, 2016
On Tuesday 7th June 2016, the first Limbal Stem Cell transplant in Ireland was performed by Mr. William Power, Consultant Ophthalmologist at the Royal Victoria Eye and Ear Hospital (RVEEH) in Dublin.   While this technique ...

Recommended for you

Sleep in your contacts, risk serious eye damage: CDC

August 16, 2018
(HealthDay)—A 59-year-old man was in the shower, wiping his eyes with a towel, when he heard a popping sound and felt pain shoot through his left eye.

Researchers reverse congenital blindness in mice

August 15, 2018
Researchers funded by the National Eye Institute (NEI) have reversed congenital blindness in mice by changing supportive cells in the retina called Müller glia into rod photoreceptors. The findings advance efforts toward ...

Autoimmune response drives vision loss in glaucoma

August 10, 2018
A research team from Massachusetts Eye and Ear and the Massachusetts Institute of Technology has shown that immune cells in the eye that developed in response to early exposure to bacteria are a key contributor to progressive ...

Is too much screen time harming children's vision?

August 6, 2018
As children spend more time tethered to screens, there is increasing concern about potential harm to their visual development. Ophthalmologists—physicians who specialize in medical and surgical eye care—are seeing a marked ...

Researchers chart a course for AI-aided diagnosis of degenerative eye conditions

August 1, 2018
A team of researchers from Johns Hopkins is leading the way in understanding how the advent of electronic medical records with large image databases and advances in artificial intelligence with deep learning can offer medical ...

Derivative of turmeric eye drops could treat glaucoma

July 24, 2018
A derivative of turmeric could be used in eye drops to treat the early stages of glaucoma, finds a new study led by UCL and Imperial College London researchers.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.